• Latest Posts

Biotech of the week: PsiOxus, “non-traditional” Immuno-oncology from Oxford

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

Cinfa Biotech’s Biosimilar is on the Starting Block!

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

ADVERTISEMENT

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

What will Happen now the Microbiome Hype has Broken into the Immuno-Oncology Field?

What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

Using Algae and NanoTech to Kill Cancer: An Australian-German Collaboration

French-Danish Clinical Trial Made Blood Cancer Disappear in 72% of Patients

ADVERTISEMENT